Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Majem, M; Manzano, JL; Marquez-Rodas, I; Mujika, K; Munoz-Couselo, E; Perez-Ruiz, E; de la Cruz-Merino, L; Espinosa, E; Gonzalez-Cao, M; Berrocal, A.

SEOM clinical guideline for the management of cutaneous melanoma (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 948-960 Nº de citas: 16 [doi:10.1007/s12094-020-02539-9]

Ferre, AD; Alvarez, RA; Herraez, AC; Jurado, JC; Gonzalez, AE; Martin-Broto, J; Marin, VM; Vega, AM; Garcia, AS; Morales, CV.

SEOM Clinical Guideline of management of soft-tissue sarcoma (2020)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(5): 922-930 Nº de citas: 32 [doi:10.1007/s12094-020-02534-0]

Martin, M; Mayer, IA; Walenkamp, AME; Lapa, C; Andreeff, M; Bobirca, A.

At the bedside: Profiling and treating patients with CXCR4-expressing cancers

JOURNAL OF LEUKOCYTE BIOLOGY. 2021; 109(5): 953-967 Nº de citas: 18 [doi:10.1002/JLB.5BT1219-714R]

Garcia-Alfonso, P; Martin, AJ; Moran, L; Alsar, J; Perez-Solero, G; Codesido, M; Ferrandiz, PA; Cicala, S.

Oral drugs in the treatment of metastatic colorectal cancer

Therapeutic Advances in Medical Oncology. 2021; 13: Nº de citas: 44 [doi:10.1177/17588359211009001]

Palka-Kotlowska, M; Custodio-Cabello, S; Oliveros-Acebes, E; Khosravi-Shahi, P; Cabezon-Gutierrez, L.

Review of risk of COVID-19 in cancer patients and their cohabitants

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2021; 105: 15-20 Nº de citas: 3 [doi:10.1016/j.ijid.2021.01.072]

Hecht, JR; Lonardi, S; Bendell, J; Sim, HW; Macarulla, T; Lopez, CD; Van Cutsem, E; Martin, AJM; Park, JO; Greil, R; Wang, H; Hozak, RR; Gueorguieva, I; Lin, Y; Rao, S; Ryoo, BY.

Randomized Phase III Study of FOLFOX Alone or With Pegilodecakin as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer That Progressed After Gemcitabine (SEQUOIA)

JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(10): 1108 Nº de citas: 74 [doi:10.1200/JCO.20.02232]

Sastre, J; Garcia-Alfonso, P; Vieitez, JM; Cano, MT; Rivera, F; Reina-Zoilo, JJ; Salud-Salvia, A; Quintero, G; Robles-Diaz, L; Safont, MJ; La Casta, A; Gil, S; Polo, E; Asensio-Martinez, E; Garcia-Paredes, B; Lopez, RL; Guillot, M; Valladares-Ayerbes, M; Aranda, E; Diaz-Rubio, E.

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and < 3 baseline circulating tumour cells: the randomised phase II VISNU-2 study

Esmo Open. 2021; 6(2): 100062-100062 Nº de citas: 7 [doi:10.1016/j.esmoop.2021.100062]

Morgan, G; Tagliamento, M; Lambertini, M; Devnani, B; Westphalen, B; Dienstmann, R; Bozovic-Spasojevic, I; Calles, A; Criscitiello, C; Curioni, A; Garcia, AM; Lamarca, A; Pilotto, S; Scheffler, M; Strijbos, M; Wong, R; de Azambuja, E; Peters, S.

Impact of COVID-19 on social media as perceived by the oncology community: results from a survey in collaboration with the European Society for Medical Oncology (ESMO) and the OncoAlert Network

Esmo Open. 2021; 6(2): 100104-100104 Nº de citas: 15 [doi:10.1016/j.esmoop.2021.100104]

Conde, E; Earl, J; Crespo-Toro, L; Blanco-Agudo, C; Ramos-Munoz, E; Rodriguez-Serrano, EM; Avila, JCM; Salinas-Munoz, L; Serrano-Huertas, S; Ferreiro, R; Rodriguez-Garrote, M; Sainz, B; Massuti, B; Alfonso, PG; Benavides, M; Aranda, E; Garcia-Bermejo, ML; Carrato, A.

Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study

Cancers. 2021; 13(7): Nº de citas: 8 [doi:10.3390/cancers13071710]

Trilla-Fuertes, L; Gamez-Pozo, A; Maurel, J; Garcia-Carbonero, R; Capdevila, J; G-Pastrian, L; Mendiola, M; Pena, C; Lopez-Vacas, R; Cuatrecasas, M; Garcia-Alfonso, P; Ramos-Ruiz, R; Llorens, C; Ghanem, I; Conill, C; Heredia-Soto, V; Campos-Barros, A; Vara, JAF; Feliu, J.

Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab

Scientific Reports. 2021; 11(1): 7402-7402 Nº de citas: 3 [doi:10.1038/s41598-021-86966-w]

Martin, M; Zielinski, C; Ruiz-Borrego, M; Carrasco, E; Turner, N; Ciruelos, EM; Munoz, M; Bermejo, B; Margeli, M; Anton, A; Kahan, Z; Csoszi, T; Casas, MI; Murillo, L; Morales, S; Alba, E; Gal-Yam, E; Guerrero-Zotano, A; Calvo, L; de la Haba-Rodriguez, J; Ramos, M; Alvarez, I; Garcia-Palomo, A; Bartlett, CH; Koehler, M; Caballero, R; Corsaro, M; Huang, X; Garcia-Saenz, JA; Chacon, JI; Swift, C; Thallinger, C; Gil-Gil, M.

Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL

ANNALS OF ONCOLOGY. 2021; 32(4): 488-499 Nº de citas: 103 [doi:10.1016/j.annonc.2020.12.013]

Munoz-Langa, J; Jimenez-Fonseca, P; Carmona-Bayonas, A; de Castro, EM; Perez-Segura, P; Canovas, MS; Gomez, D; Moran, LO; de Tejada, MBG; Segui, E; Lopez, GB; Adrian, SG; Campos, MC; Olmos, VP; Portero, BO; Moyano, MS; Crespo, JAS; Sanchez, LT; Rebollo, MA; Rivas, PO; Altozano, JP; Lescure, AR; Munoz-Martin, A.

Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology)

CLINICAL & TRANSLATIONAL ONCOLOGY. 2021; 23(4): 799-811 Nº de citas: 5 [doi:10.1007/s12094-020-02472-x]

Gonzalez-Barca, E; Capote, FJ; Gomez-Codina, J; Panizo, C; Salar, A; Sancho, JM; Lopez, A; Briones, J; Munoz, A; Encuentra, M; Mercadal, S; Domingo-Domenech, E; de Sevilla, AF.

Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients

ANNALS OF HEMATOLOGY. 2021; 100(4): 1023-1029 Nº de citas: 10 [doi:10.1007/s00277-020-04056-9]

Thavendiranathan, P; Zhang, LL; Zafar, A; Drobni, ZD; Mahmood, SS; Cabral, M; Awadalla, M; Nohria, A; Zlotoff, DA; Thuny, F; Heinzerling, LM; Barac, A; Sullivan, RJ; Chen, CL; Gupta, D; Kirchberger, MC; Hartmann, SE; Weinsaft, JW; Gilman, HK; Rizvi, MA; Kovacina, B; Michel, C; Sahni, G; Gonzalez-Mansilla, A; Calles, A; Fernandez-Aviles, F; Mahmoudi, M; Reynolds, KL; Ganatra, S; Gavira, JJ; Gonzalez, NS; Castro, MGD; Kwong, RY; Jerosch-Herold, M; Coelho, OR; Afilalo, J; Zatarain-Nicolas, E; Baksi, AJ; Wintersperger, BJ; Calvillo-Arguelles, O; Ederhy, S; Yang, EH; Lyon, AR; Fradley, MG; Neilan, TG.

Myocardial T1 and T2 Mapping by Magnetic Resonance in Patients With Immune Checkpoint Inhibitor-Associated Myocarditis

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2021; 77(12): 1503-1516 Nº de citas: 148 [doi:10.1016/j.jacc.2021.01.050]

Martin, M; Ramos-Medina, R; Bernat, R; Garcia-Saenz, JA; del Monte-Millan, M; Alvarez, E; Cebollero, M; Moreno, F; Gonzalez-Haba, E; Bueno, O; Romero, P; Massarrah, T; Echavarria, I; Jerez, Y; Herrero, B; del Val, RG; Lobato, N; Rincon, P; Palomero, MI; Marquez-Rodas, I; Lizarraga, S; Asensio, F; Lopez-Tarruella, S.

Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts

Scientific Reports. 2021; 11(1): 7064-7064 Nº de citas: 14 [doi:10.1038/s41598-021-85962-4]

Mountzios, G; de Toma, A; Economopoulou, P; Friedlaender, A; Banini, M; Lo Russo, G; Baxevanos, P; Roila, F; Banna, GL; Christopoulou, A; Jimenez, B; Collazo-Lorduy, A; Linardou, H; Calles, A; Galetta, D; Addeo, A; Camerini, A; Pizzutilo, P; Kosmidis, P; Garassino, MC; Proto, C; Signorelli, D; Metro, G.

Surgical Outcomes of Lobectomy Versus Limited Resection for Clinical Stage I Ground-Glass Opacity Lung Adenocarcinoma 2 Centimeters or Smaller

CLINICAL LUNG CANCER. 2021; 22(2): 180-192 Nº de citas: 14 [doi:10.1016/j.cllc.2020.09.017]

Rivera, F; Izquierdo-Manuel, M; Garcia-Alfonso, P; de Castro, EM; Gallego, J; Limon, ML; Alsina, M; Lopez, L; Galan, M; Falco, E; Manzano, JL; Gonzalez, E; Munoz-Unceta, N; Lopez, C; Aranda, E; Fernandez, E; Jorge, M; Jimenez-Fonseca, P.

Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

EUROPEAN JOURNAL OF CANCER. 2021; 145: 158-167 Nº de citas: 54 [doi:10.1016/j.ejca.2020.12.005]

Garcia-Alfonso, P; Diaz-Rubio, E; Abad, A; Carrato, A; Massuti, B; Ortiz-Morales, MJ; Mozo, JLM; Munoz, A; Duran, G; Sastre, J; Safont, MJ; Ferreiro, R; Rivera, F; Gonzalez, E; Valladares-Ayerbes, M; Gravalos, C; Alonso-Orduna, V; Vieitez, JM; Yubero, A; Aranda, E.

First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

DRUGS & AGING. 2021; 38(3): 219-231 Nº de citas: 3 [doi:10.1007/s40266-021-00834-w]